Catalyst

Slingshot members are tracking this event:

Medicines Company (MDCO) Announces 90-Day Interim Results from Phase 2 ORION-1 Evaluating PCSK9si in Reducing Cholesterol

Source Link:
http://www.themedicinescompany.com/investors/news/medicines-company-announces-positive-top-line-results-day-90-interim-analysis-ongoing

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MDCO
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Oct 18, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords 90-day Interim Results, Phase 2, Orion-1, Pcsk9si, Reducing Cholesterol
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.